Anaheim Bio Raises €40M in Series A Funding
Anaheim Bio, a Leiden, the Netherlands-based preclinical-stage biotechnology company, raised €40M in Series A funding. Backers included Droia Ventures, Frazier Life Sciences, RTW…
Browsing Tag